Desq Long
Sign in

Company

MapLight Therapeutics, Inc.

MPLT · CIK 0001770069

SEC FORM 4
$192,660.03

MapLight Therapeutics, Inc. (MPLT)

Sale of 16,509 shares at $11.67 per share.

Reporting Person Hanson Kristopher · Officer Title General Counsel · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001789970-26-000016 · filed 2026-09-18 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 23,145 shares at $0 per share.

Reporting Person Kroeger Christopher A. · Officer Title Chief Executive Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001658918-26-000016 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 6,020 shares at $0 per share.

Reporting Person GILLIS JONATHAN · Officer Title CAO and Interim CFO · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001709954-26-000012 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 2,222 shares at $0 per share.

Reporting Person GILLIS JONATHAN · Officer Title CAO and Interim CFO · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001709954-26-000012 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 7,730 shares at $0 per share.

Reporting Person Lillie James Woodruff · Officer Title Chief Scientific Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001728746-26-000016 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 7,730 shares at $0 per share.

Reporting Person Hanson Kristopher · Officer Title General Counsel · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001789970-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 13,360 shares at $0 per share.

Reporting Person Foff Erin Pennock · Officer Title Chief Medical Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0002021233-26-000014 · filed 2026-08-19 · View filing →

SEC FORM 4
$0.00

MapLight Therapeutics, Inc. (MPLT)

Acquisition (code A) of 6,020 shares at $0 per share.

Reporting Person Kreitzer Anatol · Officer Title Chief Discovery Officer · Transaction Code A

Traded Aug 17, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0002021238-26-000012 · filed 2026-08-19 · View filing →